Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chicago Rivet & Machine

12.86
-0.3885-2.93%
Volume:631.00
Turnover:8.06K
Market Cap:12.43M
PE:-2.21
High:12.86
Open:12.86
Low:12.86
Close:13.25
Loading ...

CVR Energy (CVI) Gets a Sell from J.P. Morgan

TIPRANKS
·
11 Apr

Top Premarket Decliners

MT Newswires Live
·
09 Apr

CVR Energy, Inc. (CVI): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout

Insider Monkey
·
09 Apr

Major shareholder announcement

GlobeNewswire
·
07 Apr

CVR Energy Appoints New Board Members, Expands Board

TIPRANKS
·
05 Apr

CVR Energy price target raised to $21 from $20 at Mizuho

TIPRANKS
·
01 Apr

Press Release: Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

Dow Jones
·
01 Apr

Reported Friday, Chicago Rivet & Machine 2024 EPS $(5.81) Down From $(4.56) YoY, Revenue $26.99M Down From $31.51M YoY

Benzinga
·
31 Mar

Press Release: Chicago Rivet & Machine Co. Announces Year-End Results of Operations

Dow Jones
·
29 Mar

CVR Energy Is Maintained at Sell by Goldman Sachs

Dow Jones
·
28 Mar

CVR Energy, Inc. (CVI): Among Stocks Receiving the Most Insider Investment in March

Insider Monkey
·
25 Mar

Carl Icahn's Strategic Acquisition of CVR Energy Inc. Shares

GuruFocus
·
21 Mar

Acelyrin, Inc. (SLRN): One of the Best Short-Term Stocks to Buy Right Now

Insider Monkey
·
18 Mar

Press Release: XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements

Dow Jones
·
18 Mar

Stocks have fallen, but wait for these signals before deciding it's time to buy

Dow Jones
·
16 Mar

Stock investors are leaping before they look as market uncertainty takes a toll

Dow Jones
·
14 Mar

Carl Icahn Makes a Bold Move with New CVR Partners Stock Purchase!

TIPRANKS
·
11 Mar

23andMe's Wild Ride: From $6 Billion to Wojcicki's Buyout Gamble--Will Investors Get Screwed?

GuruFocus.com
·
11 Mar

India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details

Benzinga
·
10 Mar

Sun Pharma to Acquire Checkpoint Therapeutics

PR Newswire
·
10 Mar